Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Commun Biol ; 7(1): 577, 2024 May 16.
Artigo em Inglês | MEDLINE | ID: mdl-38755434

RESUMO

Pseudoxanthoma elasticum (PXE) is a rare disease characterized by ectopic calcification, however, despite the widely spread effect of pro/anti-calcifying systemic factors associated with this genetic metabolic condition, it is not known why elastic fibers in the same patient are mainly fragmented or highly mineralized in clinically unaffected (CUS) and affected (CAS) skin, respectively. Cellular morphology and secretome are investigated in vitro in CUS and CAS fibroblasts. Here we show that, compared to CUS, CAS fibroblasts exhibit: a) differently distributed and organized focal adhesions and stress fibers; b) modified cell-matrix interactions (i.e., collagen gel retraction); c) imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases; d) differentially expressed pro- and anti-calcifying proteoglycans and elastic-fibers associated glycoproteins. These data emphasize that in the development of pathologic mineral deposition fibroblasts play an active role altering the stability of elastic fibers and of the extracellular matrix milieu creating a local microenvironment guiding the level of matrix remodeling at an extent that may lead to degradation (in CUS) or to degradation and calcification (in CAS) of the elastic component. In conclusion, this study contributes to a better understanding of the mechanisms of the mineral deposition that can be also associated with several inherited or age-related diseases (e.g., diabetes, atherosclerosis, chronic kidney diseases).


Assuntos
Calcinose , Elastina , Fibroblastos , Pseudoxantoma Elástico , Feminino , Humanos , Masculino , Calcinose/metabolismo , Calcinose/patologia , Células Cultivadas , Derme/metabolismo , Derme/patologia , Tecido Elástico/metabolismo , Tecido Elástico/patologia , Elastina/metabolismo , Matriz Extracelular/metabolismo , Fibroblastos/metabolismo , Fibroblastos/patologia , Pseudoxantoma Elástico/metabolismo , Pseudoxantoma Elástico/patologia , Pseudoxantoma Elástico/genética
2.
J Clin Lipidol ; 13(4): 554-562, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31253576

RESUMO

BACKGROUND: Intestinal lipid malabsorption, resulting from an impaired formation or secretion of chylomicrons and associated with severe hypobetalipoproteinemia (HBL), may be due to biallelic mutations in APOB (homozygous FHBL type-1), MTTP (abetalipoproteinemia), or SAR1B (chylomicron retention disease). OBJECTIVE: We investigated four children, each born from consanguineous parents, presenting with steatorrhea, malnutrition, accumulation of lipids in enterocytes, and severe hypocholesterolemia with an apparent recessive transmission. METHODS: We sequenced a panel of genes whose variants may be associated with HBL. RESULTS: Case 1, a 9-month-old male, was found to be homozygous for a SAR1B variant (c.49 C>T), predicted to encode a truncated Sar1b protein devoid of function (p.Gln17*). Case 2, a 4-year-old male, was found to be homozygous for a SAR1B missense variant [c.409 G>C, p.(Asp137His)], which affects a highly conserved residue close to the Sar1b guanosine recognition site. Case 3, a 6-year-old male, was found to be homozygous for an ∼6 kb deletion of the SAR1B gene, which eliminates exon 2; this deletion causes the loss of the ATG translation initiation codon in the SAR1B mRNA. The same homozygous mutation was found in an 11-month-old child (case 4) who was related to case 3. CONCLUSIONS: We report 4 children with intestinal lipid malabsorption were found to have chylomicron retention disease due to 3 novel variants in the SAR1B gene.


Assuntos
Hipobetalipoproteinemias/diagnóstico , Síndromes de Malabsorção/diagnóstico , Proteínas Monoméricas de Ligação ao GTP/genética , Criança , Pré-Escolar , Análise Mutacional de DNA , Endoscopia do Sistema Digestório , Deleção de Genes , Homozigoto , Humanos , Hipobetalipoproteinemias/genética , Lactente , Mucosa Intestinal/patologia , Lipídeos/sangue , Síndromes de Malabsorção/genética , Masculino , Mutação de Sentido Incorreto , Linhagem , Mutação Puntual
3.
Clin Chim Acta ; 403(1-2): 249-53, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19393826

RESUMO

BACKGROUND: Point mutations in the highly penetrant cancer susceptibility gene BRCA1 are responsible for the majority of hereditary breast and/or ovarian cancer. We describe a novel large rearrangement of the BRCA1 gene identified in an Italian woman affected by an early onset bilateral breast cancer and a family history of hereditary breast cancer. The proband and her parents were negative for the presence of point mutations in BRCA1 and BRCA2 genes. METHODS: Multiplex ligation-dependent probe amplification (MLPA) was used to detect rearrangements in the BRCA1 gene. The breakpoint of the rearrangement identified in the proband was defined by restriction mapping and PCR amplification. BRCA1 mRNA encoded by the mutant allele was isolated from peripheral blood. RESULTS: The proband was heterozygous for a 9.1 kb deletion spanning from intron 1 to intron 3 (g.1238_10350del) that eliminates exons 2 and 3 in the mature mRNA. In mutant mRNA exon 1a joins directly to exon 5 with no disruption of the reading frame. CONCLUSIONS: This deletion that eliminates the ATG initiation site in exon 2 and the sequence located in exons 2 and 3 encoding part of the RING finger domain of BRCA1 protein, is expected to abolish the function of this protein.


Assuntos
Códon de Iniciação/genética , Deleção de Genes , Genes BRCA1 , Regiões Promotoras Genéticas/genética , Adulto , Sequência de Bases , Neoplasias da Mama/genética , DNA Complementar/genética , Éxons/genética , Feminino , Heterozigoto , Humanos , Íntrons/genética , Masculino , Linhagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA